Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNeurology

Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain

Paolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, Meixiang Yu, Neha Pal, David Beers, Randall Carter, Stanley H. Appel, Nazem Atassi and Joseph C. Masdeu
Journal of Nuclear Medicine August 2018, 59 (8) 1260-1266; DOI: https://doi.org/10.2967/jnumed.117.203109
Paolo Zanotti-Fregonara
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belen Pascual
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaia Rizzo
2Invicro, London, United Kingdom
3Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meixiang Yu
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neha Pal
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Beers
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall Carter
4GE Global Research, Schenectady, New York; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley H. Appel
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazem Atassi
5Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Masdeu
1Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    SUV concentrations of parent compound (green lines) and whole blood (red lines) for 11C-PBR28 (A) and 18F-GE180 (B) in representative subject. Although parent concentration of 11C-PBR28 is generally lower than whole-blood concentration, opposite is true for 18F-GE180. (C) Average and SD from all subjects of parent fraction in plasma for 11C-PBR28 (dashed line) and 18F-GE180 (solid line). Metabolism rate is much slower for 18F-GE180, as parent constitutes about 70%–80% of total plasma activity at end of 90-min scan.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Time–activity curves, expressed in SUVs, of 3 representative regions from right hemisphere of brain of healthy volunteer with high-affinity binding. (A) Temporal cortex. (B) Putamen. (C) Cerebellum. SUVs of 18F-GE180 curves (○) were substantially lower (peak value of <1) than those of 11C-PBR28 curves (●) (peak value of >2), and curves were almost flat. Lines represented fitting by 2-tissue-compartment model.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Parametric images of 11C-PBR28 and 18F-GE180, obtained with Logan plot, for healthy volunteer with high-affinity binding and corresponding MR images for anatomic reference. 18F-GE180 had very low uptake in brain; therefore, vascular structures are prominently visible.

Tables

  • Figures
    • View popup
    TABLE 1

    Comparison of Kinetic Modeling Parameters for 11C-PBR28 and 18F-GE180 Using 2-Tissue-Compartment Model

    K1 (mL ⋅ cm−3 ⋅ min−1)VT (mL ⋅ cm−3)
    Region*11C-PBR2818F-GE18011C-PBR2818F-GE180
    Superior frontal cortex0.090 ± 0.012 (2.0)0.0066 ± 0.0006 (5.4)3.22 ± 0.69 (2.1)0.15 ± 0.03 (6.3)
    Temporal cortex0.096 ± 0.013 (2.3)0.0070 ± 0.0006 (5.6)3.21 ± 0.75 (2.1)0.15 ± 0.02 (3.4)
    Parietal cortex0.085 ± 0.012 (2.8)0.0082 ± 0.0023 (9.6)3.04 ± 0.70 (3.0)0.14 ± 0.04 (3.8)
    Cerebellum0.115 ± 0.014 (1.8)0.0077 ± 0.0011 (11.7)3.30 ± 0.70 (2.2)0.16 ± 0.05 (10.7)
    Average0.094 ± 0.017 (3.5)0.0070 ± 0.0016 (14.7)3.27 ± 0.66 (4.0)0.15 ± 0.03 (7.0)
    • ↵* Representative brain regions from right hemisphere.

    • Values are reported as mean ± SD. Average SEs are shown in parentheses and are expressed as percentages of variables.

    • View popup
    TABLE 2

    Comparison of Brain Exposures for 11C-PBR28, 18F-GE180, and 5 Other Radioligands

    Parameter11C-PBR2818F-GE18011C-LY2428703 (28)18F-FMPEP-d2 (30)18F-SP203 (50)11C-(R)-rolipram (31)11C-NOP-1A (32)
    TargetTSPOTSPOmGluR1CB1mGluR5PDE4NOP
    Brain SUVpeak∼2∼0.7∼0.53–4∼62–2.55–7
    Exposure SUV (0–20 min)41.1169.8202.247.837.0124.936.7
    fp (%)4.13.50.0940.635.26.410.1
    Effective exposure*1.75.90.190.301.98.03.7
    • ↵* Area under curve of input function during first 20 min multiplied by free fraction.

    • mGluR1 = metabotropic glutamate receptor 1; CB1 = cannabinoid receptors type 1; mGluR5 = metabotropic glutamate receptor 5; PDE4 = phosphodiesterase 4; NOP = nociceptin/orphanin FQ peptide.

    • Brain exposure for 11C-PBR28 and 18F-GE180, compared with that of the 5 other radioligands analyzed in Zanotti-Fregonara (28).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (8)
Journal of Nuclear Medicine
Vol. 59, Issue 8
August 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain
Paolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, Meixiang Yu, Neha Pal, David Beers, Randall Carter, Stanley H. Appel, Nazem Atassi, Joseph C. Masdeu
Journal of Nuclear Medicine Aug 2018, 59 (8) 1260-1266; DOI: 10.2967/jnumed.117.203109

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain
Paolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, Meixiang Yu, Neha Pal, David Beers, Randall Carter, Stanley H. Appel, Nazem Atassi, Joseph C. Masdeu
Journal of Nuclear Medicine Aug 2018, 59 (8) 1260-1266; DOI: 10.2967/jnumed.117.203109
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Imaging Neuroinflammation in Neurodegenerative Disorders
  • Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers
  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
  • Google Scholar

More in this TOC Section

Neurology

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Show more Neurology

Clinical

  • Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Show more Clinical

Similar Articles

Keywords

  • 11C-PBR28
  • 18F-GE180
  • TSPO
SNMMI

© 2025 SNMMI

Powered by HighWire